FG-3175

N/A

Report date: 2024/01/24 17:56:50

Base Information

Drug NameFG-3175
Drug Alias NameFG-3175
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-C-C chemokine receptor type 8Antibody-dependent cell-mediated cytotoxicity (ADCC) effects
TargetsC-C chemokine receptor type 8
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFibrogen Inc
China Registration ClassN/A

Develop Information

Active CompaniesFibrogen Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A